Malik And Malik Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-01-2025
- Paid Up Capital ₹ 0.63 M
as on 08-01-2025
- Company Age 25 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -761.52%
(FY 2020)
- Net Worth -13.80%
(FY 2020)
- Total Assets -2.79%
(FY 2020)
About Malik And Malik Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.63 M, as per Ministry of Corporate Affairs (MCA) records.
Rohit Kumar and Balveer Singh serve as directors at the Company.
- CIN/LLPIN
U51397DL2000PTC228159
- Company No.
228159
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Malik And Malik Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Kumar  | Additional Director | 26-Aug-2016 | Current |
| Balveer Singh | Additional Director | 26-Aug-2016 | Current |
Financial Performance of Malik And Malik Pharma.
Malik And Malik Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 761.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Malik And Malik Pharma?
Unlock access to Malik And Malik Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Anamya Reality Private LimitedActive 3 years 5 monthsRohit Kumar and Balveer Singh are mutual person
- Anamya Buildwell Private LimitedActive 3 years 5 months
Rohit Kumar and Balveer Singh are mutual person
- Anantah Buildcon Private LimitedActive 3 years 1 month
Rohit Kumar and Balveer Singh are mutual person
- Attreya Reality Private LimitedActive 3 years 1 month
Rohit Kumar and Balveer Singh are mutual person
- Sarvashiva Reality Private LimitedActive 2 years 4 months
Rohit Kumar and Balveer Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Malik And Malik Pharma?
Unlock and access historical data on people associated with Malik And Malik Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Malik And Malik Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Malik And Malik Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
